Global liquid packaging carton market size was valued at USD 10.72 billion in the year 2020 and is anticipated to value at USD 14.3 billion till 2027 witnessing a CAGR rate of 4.2% during the forecast period 2021-2027. The report gives a comprehensive outlook on liquid packaging carton across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of carton type (Brick Liquid Cartons, Gable Top Cartons and Shaped Liquid Cartons), by Shelf Life (Long Shelf Life Cartons and Short Shelf Life Cartons), By End User (Liquid Diary Products, Non-carbonated Soft Drinks, Liquid Foods, Alcoholic Drinks and Others) and region. This report studies global liquid packaging carton market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
In addition, global Liquid Packaging Carton market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global liquid packaging carton market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in global liquid packaging carton products. Global liquid packaging carton market expanding at significant CAGR over 2020 to 2027 due to increasing demand from food and beverage industry. Based on carton type, brick liquid cartons segment accounted for larger market revenue share in 2019 and projected gain market revenue share over the forecast period. In July 2018, Lucile Packard Children’s Hospital Stanford has recently automated their medication management in order to limit adverse drug events.